Tertiary lymphoid tissue in the tumor microenvironment: From its occurrence to immunotherapeutic implications

Giuseppe Di Caro, Giovanni Francesco Castino, Francesca Bergomas, Nina Cortese, Maurizio Chiriva-Internati, Fabio Grizzi, Alberto Mantovani, Federica Marchesi

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Recruitment of immune and inflammatory cells in the microenvironment of solid tumors is highly heterogeneous and follows patterns, varying according to the organ of origin and stage of disease, with critical roles in the process of cancer onset and progression. While adaptive cells are endowed with anti-tumor activities, inflammatory components of the immune infiltrate orchestrate an immunosuppressive microenvironment that reveals ambivalent functions of the immune contexture in the tumor milieu. The balance between opposing pro-tumoral and anti-tumoral immune pathways, which occur concomitantly in the tumor microenvironment, and the regulatory networks of these phenomena have been the target of several immunotherapeutic strategies. While the scarcity of adaptive immune effectors in tumors correlates with dismal prognosis, the pathways of activation of tumor-specific lymphocytes are yet to be fully elucidated. Recently, the occurrence of tertiary lymphoid tissue was revealed to be critical in mediating the dynamics of T cell recruitment and local activation of immune cells in the tumor microenvironment. Thus, tertiary lymphoid tissue assessment and targeting emerge as a promising approach for the design of novel prognostic immune signatures and immunotherapeutic strategies. The immunological behavior of tertiary lymphoid tissue, its occurrence in the tumor immune microenvironment and its clinical relevance are discussed here.

Original languageEnglish
Pages (from-to)123-133
Number of pages11
JournalInternational Reviews of Immunology
Volume34
Issue number2
DOIs
Publication statusPublished - Mar 4 2015

Fingerprint

Tumor Microenvironment
Lymphoid Tissue
Neoplasms
Cellular Microenvironment
Immunosuppressive Agents
Lymphocytes
T-Lymphocytes

Keywords

  • Biomarker
  • Immune infiltration
  • Prognosis
  • Tertiary Lymphoid Tissue

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Tertiary lymphoid tissue in the tumor microenvironment : From its occurrence to immunotherapeutic implications. / Di Caro, Giuseppe; Castino, Giovanni Francesco; Bergomas, Francesca; Cortese, Nina; Chiriva-Internati, Maurizio; Grizzi, Fabio; Mantovani, Alberto; Marchesi, Federica.

In: International Reviews of Immunology, Vol. 34, No. 2, 04.03.2015, p. 123-133.

Research output: Contribution to journalArticle

@article{10da0ad9e5dd48b0a381d98dcfe0c13a,
title = "Tertiary lymphoid tissue in the tumor microenvironment: From its occurrence to immunotherapeutic implications",
abstract = "Recruitment of immune and inflammatory cells in the microenvironment of solid tumors is highly heterogeneous and follows patterns, varying according to the organ of origin and stage of disease, with critical roles in the process of cancer onset and progression. While adaptive cells are endowed with anti-tumor activities, inflammatory components of the immune infiltrate orchestrate an immunosuppressive microenvironment that reveals ambivalent functions of the immune contexture in the tumor milieu. The balance between opposing pro-tumoral and anti-tumoral immune pathways, which occur concomitantly in the tumor microenvironment, and the regulatory networks of these phenomena have been the target of several immunotherapeutic strategies. While the scarcity of adaptive immune effectors in tumors correlates with dismal prognosis, the pathways of activation of tumor-specific lymphocytes are yet to be fully elucidated. Recently, the occurrence of tertiary lymphoid tissue was revealed to be critical in mediating the dynamics of T cell recruitment and local activation of immune cells in the tumor microenvironment. Thus, tertiary lymphoid tissue assessment and targeting emerge as a promising approach for the design of novel prognostic immune signatures and immunotherapeutic strategies. The immunological behavior of tertiary lymphoid tissue, its occurrence in the tumor immune microenvironment and its clinical relevance are discussed here.",
keywords = "Biomarker, Immune infiltration, Prognosis, Tertiary Lymphoid Tissue",
author = "{Di Caro}, Giuseppe and Castino, {Giovanni Francesco} and Francesca Bergomas and Nina Cortese and Maurizio Chiriva-Internati and Fabio Grizzi and Alberto Mantovani and Federica Marchesi",
year = "2015",
month = "3",
day = "4",
doi = "10.3109/08830185.2015.1018416",
language = "English",
volume = "34",
pages = "123--133",
journal = "International Reviews of Immunology",
issn = "0883-0185",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Tertiary lymphoid tissue in the tumor microenvironment

T2 - From its occurrence to immunotherapeutic implications

AU - Di Caro, Giuseppe

AU - Castino, Giovanni Francesco

AU - Bergomas, Francesca

AU - Cortese, Nina

AU - Chiriva-Internati, Maurizio

AU - Grizzi, Fabio

AU - Mantovani, Alberto

AU - Marchesi, Federica

PY - 2015/3/4

Y1 - 2015/3/4

N2 - Recruitment of immune and inflammatory cells in the microenvironment of solid tumors is highly heterogeneous and follows patterns, varying according to the organ of origin and stage of disease, with critical roles in the process of cancer onset and progression. While adaptive cells are endowed with anti-tumor activities, inflammatory components of the immune infiltrate orchestrate an immunosuppressive microenvironment that reveals ambivalent functions of the immune contexture in the tumor milieu. The balance between opposing pro-tumoral and anti-tumoral immune pathways, which occur concomitantly in the tumor microenvironment, and the regulatory networks of these phenomena have been the target of several immunotherapeutic strategies. While the scarcity of adaptive immune effectors in tumors correlates with dismal prognosis, the pathways of activation of tumor-specific lymphocytes are yet to be fully elucidated. Recently, the occurrence of tertiary lymphoid tissue was revealed to be critical in mediating the dynamics of T cell recruitment and local activation of immune cells in the tumor microenvironment. Thus, tertiary lymphoid tissue assessment and targeting emerge as a promising approach for the design of novel prognostic immune signatures and immunotherapeutic strategies. The immunological behavior of tertiary lymphoid tissue, its occurrence in the tumor immune microenvironment and its clinical relevance are discussed here.

AB - Recruitment of immune and inflammatory cells in the microenvironment of solid tumors is highly heterogeneous and follows patterns, varying according to the organ of origin and stage of disease, with critical roles in the process of cancer onset and progression. While adaptive cells are endowed with anti-tumor activities, inflammatory components of the immune infiltrate orchestrate an immunosuppressive microenvironment that reveals ambivalent functions of the immune contexture in the tumor milieu. The balance between opposing pro-tumoral and anti-tumoral immune pathways, which occur concomitantly in the tumor microenvironment, and the regulatory networks of these phenomena have been the target of several immunotherapeutic strategies. While the scarcity of adaptive immune effectors in tumors correlates with dismal prognosis, the pathways of activation of tumor-specific lymphocytes are yet to be fully elucidated. Recently, the occurrence of tertiary lymphoid tissue was revealed to be critical in mediating the dynamics of T cell recruitment and local activation of immune cells in the tumor microenvironment. Thus, tertiary lymphoid tissue assessment and targeting emerge as a promising approach for the design of novel prognostic immune signatures and immunotherapeutic strategies. The immunological behavior of tertiary lymphoid tissue, its occurrence in the tumor immune microenvironment and its clinical relevance are discussed here.

KW - Biomarker

KW - Immune infiltration

KW - Prognosis

KW - Tertiary Lymphoid Tissue

UR - http://www.scopus.com/inward/record.url?scp=84928559983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928559983&partnerID=8YFLogxK

U2 - 10.3109/08830185.2015.1018416

DO - 10.3109/08830185.2015.1018416

M3 - Article

C2 - 25901857

AN - SCOPUS:84928559983

VL - 34

SP - 123

EP - 133

JO - International Reviews of Immunology

JF - International Reviews of Immunology

SN - 0883-0185

IS - 2

ER -